About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COVID-19 Clinical Trials | 4,007 Studies Recruiting

Clinical TrialsCOVID-19

COVID-19 Clinical Trials

Browse 4,007 clinical trials for covid-19. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 961-980 of 4,007 trials

Active not recruitingNarrow Band Imaging Bronchoscopy During SARS-CoV2 InfectionVascular modifications have been described during SARS-CoV2 infection, especially a dilatation of the bronchial arteries.NCT04884061·Amiens CompletedCOVID-19: Human Epidemiology and Response to SARS-CoV-2The human disease caused by SARS-CoV-2 is called COVID-19. In most cases, COVID-19 presents as a mild to moderate respiratory illness.NCT04375761·Aurora, Colorado and 19 others

Related Searches

covid-19trials coronavirustrials sars-cov-2trials

Data from ClinicalTrials.govTerms

UnknownGenetic Predisposition to Severe Forms of COVID-19 (SARS-CoV2 Infection)The main objective of this part of the project is to identify the germline genetic factors which discriminate the benign and severe forms of SARS-CoV2 (CoVID-19) infection in the…NCT04644146·Lyon

CompletedDuvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19)In this study, patients with severe coronavirus disease 2019 (COVID-19) infection will be randomized to receive duvelisib or a placebo.NCT04487886·Atlanta, Georgia and 2 others

CompletedSERO-EPIDEMIOLOGY OF SARS-COV2 INFECTION IN THE AUTONOMOUS CITY OF BUENOS AIRESThe pandemic of a new coronavirus SARS-COV-2, which causes COVID-19 disease, has spread rapidly and is a major public health challenge.NCT04482361·Buenos Aires

TerminatedValsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection DiseaseRationale: The current SARS-CoV-2 pandemic has a high burden of morbidity and mortality due to development of the so-called acute respiratory distress syndrome (ARDS).NCT04335786·'s-Hertogenbosch and 6 others

CompletedReliability (Test-retest) of 30 Seconds Sit-to-stand and Timed Up and Go in Adults With Long CovidThe goal of this study is to test the reliability (with a test-retest process) of 30 seconds Sit to Stand and Timed Up and Go in an adult population with long-covid, hospitalised…NCT05886842·Larnaca

CompletedStudy of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized PatientsThe primary objective of this study is to evaluate the time to confirmed clinical recovery in participants hospitalized with COVID-19.NCT04590586·Anniston, Alabama and 58 others

CompletedA Randomized Trial Evaluating a mRNA-VLP Vaccine's Immunogenicity and Safety for COVID-19The purpose of this study is to characterize the safety and immunogenicity of AZD9838 and AZD6563 when administered as a single dose vaccination against SARS-CoV-2 in adults.NCT06147063·Long Beach, California and 4 others

CompletedResilience Evaluation of Caregivers During the SARS-CoV2 Epidemic Period : Prospective Cohort.The outbreak linked to SARS-CoV-2 infection was declared a Public Health Emergency of International Concern on 30 January 2020.NCT04349163·Angers

WithdrawnEfficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 PatientsHydroxychloroquine, a derivative of chloroquine (an antimalarial drug) with a weak immunosuppressive effect, is prescribed by some teams alone or in combination with azithromycin.NCT04371406

CompletedA Virtual Prospective Study Exploring Activity Trackers and COVID-19 InfectionsProspective, observational, exploratory study exploring the relationship between passively-collected data from wearable activity devices and SARS-CoV-2 infectionNCT04623138·San Mateo, California

UnknownEvaluation of the Possible Vertical Transmission of SARS-CoV-2 Through Study of Amniotic Fluid and Chorionic Villi of Affected Pregnant Women for the COVID-19Longitudinal prospective study in pregnant women withpositive serology or PCR for SARS-CoV-2 and indicationinvasive technique (amniocentesis or chorionic biopsy) that has the…NCT04598347·Barcelona

CompletedEffect of Favipiravir on Mortality in Patients With COVID-19 at a Tertiary Center Intensive Care UnitEffect of Favipiravir and Lopinavir-Ritonavir on Mortality in a Tertiary Center Intensive Care Unit: Single Center ExperienceNCT04645433·Istanbul

Active not recruitingA Longitudinal Study of COVID-19 Sequelae and ImmunityBackground: COVID-19 is a disease caused by the SARS-CoV-2 virus. It infects the respiratory tract.NCT04411147·Bethesda, Maryland

TerminatedStudy of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and OlderThe purpose of this Phase III study is to assess the efficacy, safety, and immunogenicity of two CoV2 preS dTM-AS03 vaccines (monovalent and bivalent) as part of primary series…NCT04904549·Birmingham, Alabama and 85 others

CompletedEffectiveness of Remedesvir in COVID-19 Patients Presenting at Mayo Hospital LahoreCurrently, several drugs including Remdesivir, hydroxychloroquine, chloroquine, ritonavir+lopinavir, Tocilizumab, Arbidol and interferon are under randomised controlled trials…NCT04871633·Lahore, Punjab Province

CompletedMavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammationThe purpose of this prospective, Phase 2, multicenter, blinded, randomized placebo controlled study is to demonstrate that early treatment with mavrilimumab prevents progression…NCT04463004·Richmond, Virginia

CompletedSerological Response to SARS-Cov-2 Virus in Personnel of the Institut Bergonié in the Context of the COVID-19 PandemicThe question of the immune response of the population, particularly of professional populations in contact with vulnerable populations (such as those with chronic conditions such…NCT04426006·Bordeaux

UnknownSafety & Immunogenicity of Booster SARS-CoV-2 Vaccine (Vero Cell)The 2019 Coronavirus disease outbreak (COVID-19) was first reported at the end of 2019 in Wuhan China as a severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) infection.NCT05172193·Badung, Bali and 6 others

PreviousPage 49 of 201Next